MedTrace Logo

Examining Hepatitis C Reinfection Rates in Kenya

NCT03564639 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 101

Last updated 2021-04-20

No results posted yet for this study

Summary

The goal of this research project is to build upon the Testing and Linkage to Care for Injecting Drug Users (TLC-IDU) parent study and describe post-cure HCV reinfection in a population of people who inject drugs (PWIDs) in Kenya.

Conditions

  • Hepatitis C

Sponsors & Collaborators

  • Yale University

    lead OTHER

Principal Investigators

  • Ann Kurth, PhD · Yale University School of Nursing

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-10-01
Primary Completion
2021-02-01
Completion
2021-02-01

Countries

  • Kenya

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03564639 on ClinicalTrials.gov